Aspiriant LLC’s BlackRock Enhanced Equity Dividend Trust BDJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-12,900
Closed -$128K 277
2022
Q1
$128K Buy
+12,900
New +$126K 0.01% 270

Other funds holding BDJ

Aspiriant LLC's BDJ Position: Q2 2022 in Review

Aspiriant LLC sold out of BlackRock Enhanced Equity Dividend Trust (BDJ) in Q2 2022, closing a stake of 12,900 shares — an estimated $128K sold.

Aspiriant LLC first reported a position in BDJ in Q1 2022 and held it in 1 quarter. The position peaked at $128K in Q1 2022. 186 funds tracked by Wall St. Rank hold BDJ as of Q2 2022.

  • Aspiriant LLC reported no remaining BlackRock Enhanced Equity Dividend Trust position as of Q2 2022 after selling out during the quarter.
  • Aspiriant LLC sold 12,900 BlackRock Enhanced Equity Dividend Trust shares in Q2 2022, an estimated $128K.
  • Aspiriant LLC first reported a position in BlackRock Enhanced Equity Dividend Trust in Q1 2022 and held it in 1 quarter.
  • Aspiriant LLC's BlackRock Enhanced Equity Dividend Trust position peaked at $128K in Q1 2022.
  • 186 funds tracked by Wall St. Rank held BlackRock Enhanced Equity Dividend Trust as of Q2 2022.

Based on Aspiriant LLC's 13F filing for Q2 2022, filed 25 Jul 2022.